478.71 USD
▲-4.60+1.70%
盘后 480.00 +0.61%
2026-07-31
市值
$121.26B
市盈率
27.86
EPS
16.86
股息率
—
52 周区间
362.50 – 533.67
成交量
2.03M
Beta
0.29
目标价
557.13
52W 低 362.5052W 高 533.67
价格走势
公司简介
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMK...
关联新闻
- Vertex raises annual revenue forecast on cystic fibrosis drugs strength
Vertex Pharmaceuticals on Monday raised the upper end of its annual revenue forecast, banking on robust demand for its cystic fibrosis treatments.